Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.
about
Cell of origin of transformed follicular lymphomaFollicular lymphoma: 2015 update on diagnosis and management.Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas.Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.Follicular lymphoma: 2018 update on diagnosis and management.Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.
P2860
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Outcome determinants for trans ...... ous stem-cell transplantation.
@en
Outcome determinants for trans ...... ous stem-cell transplantation.
@nl
type
label
Outcome determinants for trans ...... ous stem-cell transplantation.
@en
Outcome determinants for trans ...... ous stem-cell transplantation.
@nl
prefLabel
Outcome determinants for trans ...... ous stem-cell transplantation.
@en
Outcome determinants for trans ...... ous stem-cell transplantation.
@nl
P2093
P2860
P356
P1433
P1476
Outcome determinants for trans ...... gous stem-cell transplantation
@en
P2093
B A Jensen
F A d'Amore
L Munksgaard
P Johansen
P2860
P304
P356
10.1093/ANNONC/MDU537
P577
2014-11-18T00:00:00Z